Amicus Therapeutics Hits $14.46 52-Week High Amicus Therapeutics reached a 52-week high of $14.46 on Apr 7, 2026 (Investing.com), signaling renewed investor interest in its rare-disease franchise and commercial assets.

Amicus Therapeutics Hits $14.46 52-Week High: Amicus Therapeutics reached a 52-week high of $14.46 on Apr 7, 2026 (Investing.com), signaling renewed investor interest in its rare-disease franchise and… 👈 Read full analysis #AmicusTherapeutics #StockMarket #Investing #Healthcare #RareDiseases

Agreed Acquisitions: #Alphabet > #IntersectPower; #BioMarinPharmaceutical > #AmicusTherapeutics; #CACIInternational > #ARKAGroup; #CoinbaseGlobal > #TheClearingCompany; #Samsung > #ZFFriedrichshafen;
#ServiceNow > #Armis; #Snowflake > #Observe